24-Hour Compared With 12-Hour Mifepristone–Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial

To compare 24-hour and 12-hour mifepristone-to-misoprostol intervals for second-trimester medication abortion.OBJECTIVETo compare 24-hour and 12-hour mifepristone-to-misoprostol intervals for second-trimester medication abortion.We conducted a prospective randomized controlled trial. Participants we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obstetrics and gynecology (New York. 1953) 2024-07, Vol.144 (1), p.60
Hauptverfasser: Meyer, Raanan, Toussia-Cohen, Shlomi, Shats, Maya, Segal, Omri, Mohr-Sasson, Aya, Peretz-Bookstein, Shiran, Amitai-Komem, Daphna, Sindel, Ofra, Levin, Gabriel, Mashiach, Roy, Blumenthal, Paul D.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To compare 24-hour and 12-hour mifepristone-to-misoprostol intervals for second-trimester medication abortion.OBJECTIVETo compare 24-hour and 12-hour mifepristone-to-misoprostol intervals for second-trimester medication abortion.We conducted a prospective randomized controlled trial. Participants were allocated to receive mifepristone either 24 hours or 12 hours before misoprostol administration. The primary outcome was the time from the first misoprostol administration to abortion (induction time). Secondary outcomes included the time from mifepristone to abortion (total abortion time); fetal expulsion percentages at 12, 24, and 48 hours after the first misoprostol dose; side effects proportion; and pain and satisfaction scores. A sample size of 40 per group (N=80) was planned to compare the 24- and 12-hour regimens.METHODSWe conducted a prospective randomized controlled trial. Participants were allocated to receive mifepristone either 24 hours or 12 hours before misoprostol administration. The primary outcome was the time from the first misoprostol administration to abortion (induction time). Secondary outcomes included the time from mifepristone to abortion (total abortion time); fetal expulsion percentages at 12, 24, and 48 hours after the first misoprostol dose; side effects proportion; and pain and satisfaction scores. A sample size of 40 per group (N=80) was planned to compare the 24- and 12-hour regimens.Eighty patients were enrolled between July 2020 and June 2023, with 40 patients per group. Baseline characteristics were comparable between groups. Median induction time was 9.5 hours (95% CI, 10.3-17.8 hours) and 12.5 hours (95% CI, 13.5-20.2 hours) in the 24- and 12-hour interval arms, respectively ( P =.028). Median total abortion time was 33.0 hours (95% CI, 34.2-41.9 hours) and 24.5 hours (95% CI, 25.7-32.4 hours) in the 24- and 12-hour interval groups, respectively ( P
ISSN:0029-7844
1873-233X
1873-233X
DOI:10.1097/AOG.0000000000005535